Items where Author is "Malekzadeh, R."

Article

(2022) Does Opium Consumption Have Shared Impact on Atherosclerotic Cardiovascular Disease and Cancer? ARCHIVES OF IRANIAN MEDICINE. pp. 50-63. ISSN 1029-2977 1735-3947 J9 - ARCH IRAN MED

(2022) The Effectiveness of Silicone-Based Non-Lead Nanoparticles for Radiation Protection of Patients in Diagnostic Radiology by Monte Carlo Simulation. Journal of Isfahan Medical School. pp. 860-866. ISSN 10277595 (ISSN)

(2022) Prediction of Cardiovascular Disease Mortality in a Middle Eastern Country: Performance of the Globorisk and Score Functions in Four Population-Based Cohort Studies of Iran. Int J Health Policy Manag. pp. 210-217. ISSN 2322-5939

(2022) An office-based cardiovascular prediction model developed and validated in cohort studies of a middle-income country. JOURNAL OF CLINICAL EPIDEMIOLOGY. pp. 1-11. ISSN 0895-4356 1878-5921 J9 - J CLIN EPIDEMIOL

(2021) Cancer in Iran 2008 to 2025: Recent incidence trends and short-term predictions of the future burden. International Journal of Cancer. pp. 594-605. ISSN 00207136 (ISSN)

(2021) The Prospective Epidemiological Research Studies in IrAN (PERSIAN) Birth Cohort protocol: rationale, design and methodology. Longitudinal and Life Course Studies. pp. 241-262. ISSN 1757-9597

(2021) SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study. Lancet Infect Dis. pp. 473-481. ISSN 1473-3099 (Print) 1473-3099

(2020) COVID19 Prevention & Care; A Cancer Specific Guideline. Archives of Iranian Medicine. pp. 255-264. ISSN 1029-2977

(2020) Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. The Lancet. pp. 1160-1203. ISSN 01406736 (ISSN)

(2020) Knowledge production in Iranian cardiovascular research centers: A way to reduce the burden of disease. ARYA Atherosclerosis. pp. 72-78. ISSN 1735-3955

(2020) Prediction of Cardiovascular Disease Mortality in a Middle Eastern Country: Performance of the Globorisk and Score Functions in Four Population-Based Cohort Studies of Iran. Int J Health Policy Manag. ISSN 2322-5939

(2020) SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial. Clinical Infectious Diseases. pp. 2206-2212. ISSN 1058-4838

(2020) Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial. International Immunopharmacology. ISSN 1567-5769

(2020) The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment. Journal of Gastroenterology and Hepatology. pp. 1590-1594. ISSN 0815-9319

(2019) Cancer incidence in Iran in 2014: Results of the Iranian National Population-based Cancer Registry. Cancer Epidemiology. pp. 50-58. ISSN 18777821 (ISSN)

(2019) Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial. Lancet. pp. 672-683. ISSN 0140-6736

(2019) Iran in transition. Lancet. pp. 1984-2005. ISSN 0140-6736

(2019) Iranian Registry of Crohn's and Colitis (IRCC): first nation-wide IBD registry in Middle East, a study protocol. Journal of Crohns & Colitis. S492-S493. ISSN 1873-9946

(2019) Iranian Registry of Crohn's and Colitis: study profile of first nation-wide inflammatory bowel disease registry in Middle East. Intest Res. ISSN 1598-9100 (Print) 1598-9100 (Linking)

(2019) The combination of sofosbuvir and daclatasvir is well tolerated and extremely effective in treating patients with hepatitis C with severe renal impairment including hemodialysis patinets. Journal of Hepatology. E233-E233. ISSN 0168-8278

(2018) Cardiovascular mortality in a Western Asian country: results from the Iran Cohort Consortium. Bmj Open. ISSN 2044-6055

(2018) Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: A pooled analysis of 1018 population-based measurement studies with 88.6 million participants. International Journal of Epidemiology. 872-883i. ISSN 03005771 (ISSN)

(2018) Liver Transplantation Status in Iran: A Multi-center Report on the Main Transplant Indicators and Survival Rates. Archives of Iranian Medicine. pp. 275-282. ISSN 1029-2977

(2018) Molecular evolution and phylodynamics of hepatitis B virus infection circulating in Iran. Archives of Virology. pp. 1479-1488. ISSN 0304-8608

(2018) Prospective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study): Rationale, Objectives, and Design. AMERICAN JOURNAL OF EPIDEMIOLOGY. pp. 647-655. ISSN 00029262 (ISSN)

(2018) SD1000: 96.4 SVR12 in 1237 patients with hepatitis C genotypes 1, 2, 3, 4 using co-formulated sofosbuvir/daclatasvir tablets manufactured in Iran - a multicenter phase 3 clinical trial including HIV co-infected, transplant, and hemodialysis patients. Journal of Viral Hepatitis. pp. 198-199. ISSN 1352-0504

(2016) The Combined Effects of Healthy Lifestyle Behaviors on All-Cause Mortality: The Golestan Cohort Study. Archives of Iranian Medicine. pp. 752-761. ISSN 1029-2977

(2016) Emerging Epidemic of Inflammatory Bowel Disease in a Middle Income Country: A Nation-wide Study from Iran. Archives of Iranian Medicine. pp. 2-15. ISSN 1029-2977

(2016) Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline. Hepatitis Monthly. ISSN 1735-143X

(2015) Evolution of hepatitis B virus surface gene and protein among Iranian chronic carriers from different provinces. Iranian journal of microbiology. pp. 214-20. ISSN 2008-3289 (Print) 2008-3289 (Linking)

(2015) Polypill for the prevention of cardiovascular disease (PolyIran): study design and rationale for a pragmatic cluster randomized controlled trial. European Journal of Preventive Cardiology. pp. 1609-1617. ISSN 2047-4873